3381 - 3390 of 8587 Results
Title
Year
- Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease2008OPENTitle: Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci36470Best OA location URL: http://doi.org/10.1172/JCI36470Citation Count: 1099
-
OPENTitle: A causal link between prediction errors, dopamine neurons and learningJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 16Issue #: 7Start Page: 966End Page: 973Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3413Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3705924Citation Count: 893
- Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome2022OPENTitle: Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01113-5Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01113-5Citation Count: 129
-
OPENTitle: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13073-022-01132-9Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-022-01132-9Citation Count: 9
-
OPENTitle: LRRK2 kinase activity regulates Parkinson’s disease-relevant lipids at the lysosomeJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00880-7Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00880-7Citation Count: 0
- Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort2022OPENTitle: Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohortJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-022-00964-1Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/s13041-022-00964-1Citation Count: 32
-
OPENTitle: Clinical progression and genetic pathways in body-first and brain-first Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00866-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00866-5Citation Count: 0
- The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons2024RESTRICTEDTitle: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00779-9Best OA location URL: https://link.springer.com/content/pdf/10.1186/s13024-024-00779-9.pdfCitation Count: 9
- Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study2023OPENTitle: Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort studyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-023-02843-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/s12974-023-02843-5Citation Count: 25
- Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances2024OPENTitle: Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbancesJournal Name: BMC MedicinePublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12916-024-03766-5Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12916-024-03766-5.pdfCitation Count: 1